BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8622867)

  • 21. Homodimerization of the c-Abl protein tyrosine kinase.
    Wei L; Liu X; Yi YP; Li CF; Wang YL; Cao C
    Sheng Wu Gong Cheng Xue Bao; 2005 Sep; 21(5):698-702. PubMed ID: 16285507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. c-Abl tyrosine kinase regulates c-fos gene expression via phosphorylating RNA polymerase II.
    Jing Y; Song Z; Wang M; Tang W; Hao S; Zeng X
    Arch Biochem Biophys; 2005 May; 437(2):199-204. PubMed ID: 15850559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of B cell adaptor for PI3-kinase (BCAP) as an Abl interactor 1-regulated substrate of Abl kinases.
    Maruoka M; Suzuki J; Kawata S; Yoshida K; Hirao N; Sato S; Goff SP; Takeya T; Tani K; Shishido T
    FEBS Lett; 2005 Jun; 579(14):2986-90. PubMed ID: 15893754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drosophila abelson interacting protein (dAbi) is a positive regulator of abelson tyrosine kinase activity.
    Juang JL; Hoffmann FM
    Oncogene; 1999 Sep; 18(37):5138-47. PubMed ID: 10498863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein-acrylamide copolymer hydrogels for array-based detection of tyrosine kinase activity from cell lysates.
    Brueggemeier SB; Wu D; Kron SJ; Palecek SP
    Biomacromolecules; 2005; 6(5):2765-75. PubMed ID: 16153117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. c-ABL tyrosine kinase activity is regulated by association with a novel SH3-domain-binding protein.
    Zhu J; Shore SK
    Mol Cell Biol; 1996 Dec; 16(12):7054-62. PubMed ID: 8943360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a binding site in c-Ab1 tyrosine kinase for the C-terminal repeated domain of RNA polymerase II.
    Baskaran R; Chiang GG; Wang JY
    Mol Cell Biol; 1996 Jul; 16(7):3361-9. PubMed ID: 8668151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abrogation of retinoblastoma protein function by c-Abl through tyrosine kinase-dependent and -independent mechanisms.
    Welch PJ; Wang JY
    Mol Cell Biol; 1995 Oct; 15(10):5542-51. PubMed ID: 7565706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity.
    Wen ST; Van Etten RA
    Genes Dev; 1997 Oct; 11(19):2456-67. PubMed ID: 9334312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Constitutive Activity in an Ancestral Form of Abl Tyrosine Kinase.
    Aleem SU; Craddock BP; Miller WT
    PLoS One; 2015; 10(6):e0131062. PubMed ID: 26090675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of ABL kinase catalytic efficiency by a direct binding regulator is independent of other regulatory mechanisms.
    Cao X; Tanis KQ; Koleske AJ; Colicelli J
    J Biol Chem; 2008 Nov; 283(46):31401-7. PubMed ID: 18796434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small molecule probes that target Abl kinase.
    Kalesh KA; Sim DS; Wang J; Liu K; Lin Q; Yao SQ
    Chem Commun (Camb); 2010 Feb; 46(7):1118-20. PubMed ID: 20126732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA.
    Kipreos ET; Wang JY
    Science; 1992 Apr; 256(5055):382-5. PubMed ID: 1566087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for regulation of the human ABL tyrosine kinase by a cellular inhibitor.
    Pendergast AM; Muller AJ; Havlik MH; Clark R; McCormick F; Witte ON
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5927-31. PubMed ID: 1712111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. c-Abl tyrosine kinase regulates the human Rad9 checkpoint protein in response to DNA damage.
    Yoshida K; Komatsu K; Wang HG; Kufe D
    Mol Cell Biol; 2002 May; 22(10):3292-300. PubMed ID: 11971963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assay development and high-throughput screening of small molecular c-Abl kinase activators.
    Cottom J; Hofmann G; Siegfried B; Yang J; Zhang H; Yi T; Ho TF; Quinn C; Wang DY; Johanson K; Ames RS; Li H
    J Biomol Screen; 2011 Jan; 16(1):53-64. PubMed ID: 20938045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear tyrosine kinases: from Abl to WEE1.
    Pendergast AM
    Curr Opin Cell Biol; 1996 Apr; 8(2):174-81. PubMed ID: 8791414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase.
    Yuan ZM; Huang Y; Ishiko T; Kharbanda S; Weichselbaum R; Kufe D
    Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1437-40. PubMed ID: 9037071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global Regulation of Differential Gene Expression by c-Abl/Arg Oncogenic Kinases.
    Dong Q; Li C; Qu X; Cao C; Liu X
    Med Sci Monit; 2017 May; 23():2625-2635. PubMed ID: 28555614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. c-Abl stabilizes HDAC2 levels by tyrosine phosphorylation repressing neuronal gene expression in Alzheimer's disease.
    Gonzalez-Zuñiga M; Contreras PS; Estrada LD; Chamorro D; Villagra A; Zanlungo S; Seto E; Alvarez AR
    Mol Cell; 2014 Oct; 56(1):163-73. PubMed ID: 25219501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.